DOI:
10.1055/s-00000075
Seminars in Respiratory and Critical Care Medicine
LinksClose Window
References
Johnson and Johnson Pharmaceutical Research and Development.
FDA Issues Complete Response Letter for Ceftobiprole. 2009.
Available at:
http://www.investor.jnj.com/releasedetail.cfm?ReleaseID=433517.Accessed 17 November, 2013
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.